Shares of Meta Platforms soared Thursday, fueled by a significant price target upgrade from BofA Securities. The rally comes despite the company reporting a slight dip in full-year profit, as investors focus on strong revenue growth and the company's positioning in the artificial intelligence race.
Despite modest earnings growth, Thai Beverage (SGX:Y92) has seen its share price tumble 40% over five years, leaving long-term investors with a significant total return deficit. We examine the disconnect between fundamentals and market sentiment.
Equity Lifestyle Properties (ELS) reported solid 2025 results with NOI and FFO growth, driven by its core manufactured housing communities. While forecasting further growth for 2026, management acknowledged ongoing fluctuations in its seasonal RV business and provided detailed guidance.
Cardinal Energy Ltd. has upsized its equity offering to C$95.15 million, with proceeds aimed at debt repayment and accelerating its thermal oil projects, including the Reford 2 SAGD development. The move highlights the company's strategic pivot but raises questions about dividend sustainability and shareholder dilution in a capital-intensive sector.
Asian markets opened to a volatile session Friday, with Bitcoin leading a sharp crypto sell-off and stocks swinging as traders weighed President Trump's signals on a key Fed nomination and a deal to avert a government shutdown.
The Texas-based financial institution reported a year-over-year increase in profits, deposits, and loans for the second quarter of 2025. While management highlighted the success of its organic branch expansion strategy, it also acknowledged intensifying competitive pressures in key lending markets.
Colony Bankcorp (CBAN) reported improved operating performance in Q4 2025, with executives detailing on-track integration of TC Federal and momentum in fee-based businesses. The bank targets a 1.20% return on assets for 2026 and signals appetite for further acquisitions.
President Trump is preparing to nominate former Fed Governor Kevin Warsh to lead the central bank, according to people familiar with the discussions, a move that triggered immediate market reactions as investors assessed the potential policy shift.
President Trump is expected to nominate former Fed governor Kevin Warsh as the next Federal Reserve Chair, a move that could signal a pivot toward aggressive rate cuts paired with a reduction of the central bank's balance sheet, reshaping the landscape for markets and cryptocurrencies.
Despite a recent 15% share price decline, EPB Group Berhad (KLSE:EPB) presents a complex picture with respectable financial fundamentals. We analyze its Return on Equity and growth trajectory to assess if this is a buying opportunity or a sign of deeper issues.
Simon Property Group (SPG), the premier mall REIT, is back in the spotlight following years of impressive total returns. As its share price momentum continues, investors are scrutinizing whether its current valuation still presents an attractive entry point for income and growth.
A deep dive into the intrinsic value of Aurelius Technologies Berhad (KLSE:ATECH) using a Discounted Cash Flow model suggests a potential disconnect between its market price and fundamental valuation, raising questions for investors.
Brookfield Infrastructure Partners capped a strong 2025 with double-digit FFO growth, a record capital recycling program, and a raised distribution. Management highlighted a massive, disciplined expansion in data infrastructure to meet AI-driven demand, forecasting a return to 10%+ growth targets.
Axis Capital (AXS) reported robust 2025 results, marked by record premiums and its best underwriting performance in over a decade. While outlining a confident growth trajectory, executives struck a cautious note on cyber insurance and reinsurance headwinds for the coming year.
Axos Financial (NYSE: AX) reported strong fiscal Q2 2026 results, with net income jumping to $128.4 million. Driven by broad-based loan growth and contributions from Verdant Commercial Capital, the digital bank highlighted expanding margins, improved credit metrics, and a confident outlook for continued mid-teens annual loan growth.
British pharmaceutical giant AstraZeneca has entered a strategic partnership with China's CSPC Pharmaceutical, committing over $1 billion upfront to co-develop next-generation obesity therapies, signaling intensified competition in the lucrative global weight-loss drug market.
Regeneron Pharmaceuticals' shares have softened in recent weeks, lagging behind broader market gains. A deep dive into valuation metrics, including DCF analysis and P/E ratios, suggests the biotech giant may be significantly undervalued. We examine the numbers behind the headlines and what they mean for investors.
As Western Digital prepares to report its fiscal Q2 2026 results and host a key Innovation Day, investors are watching to see if the company's product roadmap and market commentary can justify its soaring stock price and meet burgeoning AI-driven storage demand.
Shares of industrial distributor QXO have soared over 70% in the past year, prompting investors to question if the rally has run its course. A deep dive into the valuation metrics, however, suggests the market may still be underestimating the company's cash flow potential.
British American Tobacco's shares have soared over 138% in five years, but a deep dive into its valuation reveals a complex picture. While a discounted cash flow model suggests significant upside, its premium P/E ratio tells a more cautious tale, leaving investors to question if the rally has further to run.
